Name: (4S,7R,8S,9S,13Z,16S)-4,8-Bis-{[tert-butyl(dimethyl)silyl]oxy}-5,5,7,9,13-pentamethyl-16-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]oxocyclohexadec-13-ene-2,6-dione
Brand: TRC
SKU: TRC-B415780

Product support

查看收藏夹

您是否要继续？

{{requestQuote.productName}}; {{requestQuote.displayProductCode}}

登录以自动填写

电话号码

送货地址 *

送货地址

Not the right shipping address?

机构名称 *

地址第1行 *

地址第2行

国家 *

城市 *

Select from existing

账单地址 *

机构名称 *

地址第1行 *

地址第2行

国家 *

城市 *

Desired delivery date

所需准确重量

Additional requirements

Alternatives acceptable if checked, we will discuss alternatives with you if we are unable to fill your request from existing stock

Multiple lots acceptable if checked, the order may be filled from multiple different lots

Recurring need check to inform us that you intend to order again. Leave unchecked if this is a one-time order

取消

谢谢

我们将很快回复您的问询。

Something went wrong, please try again later.

Product Overview

产品代码

TRC-B415780

CAS登记号

189453-35-8

产品形式

Neat

分子式

C39 H69 N O5 S Si2

分子量

720.20

产品类型

TRC, Macrolides, Pharmaceutical Toxicology Reference Materials

产品信息

分析物名称

(4S,7R,8S,9S,13Z,16S)-4,8-Bis-{[tert-butyl(dimethyl)silyl]ox

CAS登记号

189453-35-8

分子式

C39 H69 N O5 S Si2

分子量

720.20

精确质量测定

719.4435

SMILES

C[C@H]1CCC\C(=C/C[C@H](OC(=O)C[C@H](O[Si](C)(C)C(C)(C)C)C(C)(C)C(=O)[C@H](C)[C@H]1O[Si](C)(C)C(C)(C)C)\C(=C\c2csc(C)n2)\C)\C

InChI

InChI=1S/C39H69NO5SSi2/c1-26-19-18-20-27(2)35(45-48(16,17)38(9,10)11)29(4)36(42)39(12,13)33(44-47(14,15)37(6,7)8)24-34(41)43-32(22-21-26)28(3)23-31-25-46-30(5)40-31/h21,23,25,27,29,32-33,35H,18-20,22,24H2,1-17H3/b26-21-,28-23+/t27-,29+,32-,33-,35-/m0/s1

IUPAC

(4S,7R,8S,9S,13Z,16S)-4,8-bis[[tert-butyl(dimethyl)silyl]oxy]-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

运输温度

Room Temperature

原产国

CANADA

产品形式

Neat

An intermediate in the synthesis of Epothilones. Epothilones are polyketide natural products that inhibit cancer cells by a mechanism similar to paclitaxel, and also are effective against paclitaxel-resistant tumours. Epothilone D is in phase I clinical testing of in patients with advanced solid tumours. Epothilone D is a cytotoxic macrolide that stabilises malignant cells' microtubules and arrests mitosis, a characteristic it shares with other epothilones. They bind to the same hepatic sites as does paclitaxel (Taxol) in a 1:1 stoichiometric ratio of a, b-tubulin heterodimers.

References: Hoee, G., et al.: Pure Appl. Chem., 71, 11, 2019 (1999), Giannakakou, P., et al.: Proc. Natl. Acad. Sci. USA, 97, 2904 (2000)

谢谢

{{entry.product.manufacturer}}

{{entry.product.name}}

谢谢

Product Overview

产品信息

Chemical Data

产品数据

Product Description

产品引语

谢谢

{{entry.product.manufacturer}}

{{entry.product.name}}

(4S,7R,8S,9S,13Z,16S)-4,8-Bis-{[tert-butyl(dimethyl)silyl]oxy}-5,5,7,9,13-pentamethyl-16-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]oxocyclohexadec-13-ene-2,6-dione

谢谢

Share product

Product Overview

产品信息

Chemical Data

产品数据

Product Description

产品引语

{{title}}

谢谢